Clinical Trial Update: MENOPUR® in a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population [Phase 4]

View source ↗

Summary

Phase 4 trial update on MENOPUR in a GnRH antagonist cycle with single-blastocyst transfer in high responders; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Menopur (menotropins)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Infertility | Phase 4 | Status: COMPLETED | Results posted: 2018-03-02